跳至主要内容
临床试验/NCT04407052
NCT04407052Unknown2 期

Double Trigger in Patients With Low Proportion of Mature Oocytes. A Randomized Controlled Trial

Riyadh Fertility and Reproductive Health center1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2020年5月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
66
试验地点
1
主要终点
Number of oocytes retrieved

研究概览

简要总结

The aim of this randomized controlled trial is to determine whether co-administration of GnRH agonist and hCG for final oocyte maturation ( 40 and 34 h prior to oocyte retrieval , respectively) can increase the number of mature oocytes in patients with history of low proportion of mature oocytes in previous IVF cycle triggered by HCG.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients with history of low proportion of mature oocytes in previous IVF attempt (triggered by HCG).
  • Patients with 6 to 15 mature follicles on the day oocyte trigger in the current IVF-ET attempt

排除标准

  • Endometriosis

研究组 & 干预措施

Double trigger

Experimental

GnRH-agonist and HCG are used to trigger ovulation

干预措施: Double trigger (Drug)

HCG

Active Comparator

HCG is used to trigger ovulation

干预措施: HCG trigger (Drug)

结局指标

主要结局

Number of oocytes retrieved

时间窗: First day after oocyte retrieval

次要结局

  • Clinical pregnancy rate(First 5 weeks after oocyte retrieval)

研究者

发起方
Riyadh Fertility and Reproductive Health center
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Double Trigger in Patients With Low Proportion of... | 临床试验